A study has been conducted by team of doctors from Medanta Gurugram, India that suggests possible increase in non-smokers and women lung cancer cases. Dr. Arvind Kumar and his team studied 304…
Tag: Lung Cancer News
US FDA Approves Imfinzi and Imjudo with Chemotherapy for Lung Cancer
AstraZeneca’s Imfinzi in combination with Imjudo plus platinum-based chemotherapy has been approved for treatment of patients with Stage IV non-small cell lung cancer (NSCLC). The approval has been made by the Food…
Study Shows Circadian Rhythm Disruptions Linked To Enhanced Lung Cancer Growth
According to a new paper co-authored by University of Rochester Wilmot Cancer Institute investigator and led by the Scripps Research Institute in California, a vital molecular link is between growth of lung…
Electronic Nose to Detect Lung Cancer, Research Suggests
Research work and studies are continuously being done in the arena of lung cancer. Scientists and researchers continue to experiment new and effective ways to detect it at an early stage so…
Scientists Discover New Gene Target for Aggressive Small Cell Lung Cancer
Lung cancer is the leading cause of cancer deaths in the United States. According to the American Cancer Society, an estimated 131,880 lung cancer deaths are predicted for this year alone. Though…
Over 55 Who Have Smoked Should Get Lung Cancer Scan, Says UK Health Experts
Lung cancer remains one of the major causes of cancer related deaths across the world including the United Kingdom. About 72% of lung cancer cases in UK are caused by smoking. Lung…
Indian Spices, Black Cardamom, Effective against Lung Cancer Cells: NUS Study
A team of researchers from the NUS Faculty of Science, the NUS Yong Lu Lin School of Medicine, and the NUS College of Design and Engineering explored the scientific basis of black…
FDA Grants Approval to Trastuzumab Deruxtecan for HER2 Lung Cancer
Lung cancer patients now have another treatment option. For those tumors carrying HER2 mutations, can now be treated with trastuzumab deruxtecan. This drug is already approved for use in HER2-positive breast cancer…